China Biotech Services Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08CEO
China Biotech Services Holdings has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & Compliance Officer | 7.3yrs | HK$5.01m | 54.38% HK$ 254.7m | |
| CTO & Executive Director | 5yrs | HK$580.00k | no data | |
| Executive Director | no data | HK$1.06m | 0% HK$ 0 | |
| Chief Scientific Officer | no data | no data | no data | |
| Consultant | 3.6yrs | HK$1.70m | no data | |
| Company Secretary | 7.2yrs | no data | no data |
4.3yrs
Average Tenure
57yo
Average Age
Experienced Management: 8037's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & Compliance Officer | 7.3yrs | HK$5.01m | 54.38% HK$ 254.7m | |
| CTO & Executive Director | 7.3yrs | HK$580.00k | no data | |
| Executive Director | 6.3yrs | HK$1.06m | 0% HK$ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 7.3yrs | HK$240.00k | no data | |
| Independent Non-Executive Director | 6.8yrs | HK$240.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non Executive Director | less than a year | no data | no data |
7.0yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 8037's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 14:54 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Biotech Services Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|